Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis

Cancer Research

Volumn 65, Issue 5, 2005, Pages 1655-1663

  Shidara, Yujiro ^a,b   Yamagata, Kumi ^b   Kanamori, Takashi ^b   Nakano, Kazutoshi ^a   Kwong, Jennifer Q ^c   Manfredi, Giovanni ^c   Oda, Hideaki ^a   Ohta, Shigeo ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL CULTURE; CELL NUCLEUS; CELL RESPIRATION; CODON; CONTROLLED STUDY; CYBRID; DNA TRANSFECTION; GENE FREQUENCY; GENETIC CODE; HELA CELL; HUMAN; HUMAN CELL; INFANT; INTERMETHOD COMPARISON; MALE; MITOCHONDRIAL ENCEPHALOMYOPATHY; MITOCHONDRIAL GENETICS; MOUSE; NONHUMAN; NUDE MOUSE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPECIES COMPARISON; TRANSPLANTATION; TUMOR GROWTH; TUMOR PROMOTION; WILD TYPE;

ADENOSINE TRIPHOSPHATASES; ADOLESCENT; ANIMALS; APOPTOSIS; CELL NUCLEUS; DNA, MITOCHONDRIAL; FEMALE; FIBROBLASTS; GENOME; HELA CELLS; HUMANS; HYBRID CELLS; INFANT; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOCHONDRIA; MITOCHONDRIAL ENCEPHALOMYOPATHIES; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; NEOPLASMS, EXPERIMENTAL; OXYGEN; POINT MUTATION; SKIN;

EID: 16444386967     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-2012     Document Type: Article

References (48)

1. Carew JS, Huang P. Mitochondrial defects in cancer. Mol Cancer 2002;1:9.
2. Polyak K, Li Y, Zhu H, et al. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 1998;20:291-3.
3. Fliss MS, Usadel H, Caballero OL, et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 2000;287:2017-9.
4. Liu VW, Shi HH, Cheung AN, et al. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res 2001;61:5998-6001.
5. Parrella P, Xiao Y, Fliss M, et al. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res 2001;61:7623-6.
6. Maximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Simoes M. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurthle cell tumors. Am J Pathol 2002;160:1857-65.
7. Tan DJ, Bai RK, Wong LJ. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res 2002;62:972-6.
8. Yeh JJ, Lunetta KL, van Orsouw NJ, et al. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours. Oncogene 2000;19:2060-6.
9. Coller HA, Khrapko K, Bodyak ND, Nekhaeva E, Herrero-jimenez P, Thilly WG. High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet 2001;28:147-50.
10. Linnartz B, Anglmayer R, Zanssen S. Comprehensive scanning of somatic mitochondrial DNA alterations in acute leukemia developing from myelodysplastic syndromes. Cancer Res 2004;64:1966-71.
11. Amuthan G, Biswas G, Zyang SY, Klein-Szanto A, Vijayasarathy C, Avadhani NG. Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion. EMBO J 2001;20:1910-20.
12. Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000;287:848-51.
13. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000;26:268-70.
14. Tomlinson IP, Alam NA, Rowan AJ, et al. Multiple Leiomyoma Consortium. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 2002;30:406-10.
15. Eng C, Kiuru M, Fernandez MJ, Aaltonen LA. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 2003;3:193-202.
16. Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990;46:428-33.
17. Tatuch Y, Christodoulou J, Feigenbaum A, et al. Heteroplasmic mtDNA mutation (T-G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 1992;50:852-8.
18. King MP, Attardi G. Human cells lacking mtDNA: reputation with exogenous mitochondria by complementation. Science 1989;246:500-3.
19. Hayashi J-I, Ohta S, Kikuchi A, Takemitsu M, Goto Y, Nonaka I. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci U S A 1991;88:10614-8.
20. Manfredi G, Fu J, Ojaimi J, et al. Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus. Nat Genet 2002;30:394-9.
21. Nakano K, Ohsawa I, Yamagata K, et al. Continuous culture of novel mitochondrial cells lacking nuclei. Mitochondrion 2003;3:21-7.
22. Thyagarajan D, Shanske S, Vazquez-Memije M, De Vivo D, DiMauro S. A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis. Ann Neurol 1995;38:468-72.
23. Didenko VV, Boudreaux DJ, Baskin DS. Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligoprobes. Biotechniques 1999;27:1130-2.
24. Gong J, Traganos F, Darzynkiewicz Z. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 1994;218:314-19.
25. Telford WG, King LE, Fraker PJ. Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry. J Immunol Methods 1994;172:1-16.
26. DiMauro S, Schon EA. Mitochondorial DNA mutations in human disease. Am J Med Genet 2001;106:18-26.
27. Mattiazzi M, Vijayvergiya C, Gajewski CD, et al. The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants. Hum Mol Genet 2004;13:869-79.
28. Di X, Nishizaki T, Harada K, Kajiwara K, Nakayama H, Ito H. Proliferative potentials of glioma cells and vascular components determined with monoclonal antibody MIB-1. J Exp Clin Cancer Res 1997;16:153-7.
29. Warburg O. On the origin cancer cells. Science 1956;123:309-14.
30. Houstek J, Klement P, Hermanska J, et al. Altered properties of mitochondrial ATP-synthase in patients with a T→G mutation in the ATPase6 (subunit a) gene at position 8993 of mtDNA. Biochim Biophys Acta 1995;1271:349-57.
31. Modica-Napolitano JS, Singh KK. Mitochondria as targets for detection and treatment of cancer. Expert Rev Mol Med 2002;2002:1-1932.
32. Nishikawa M, Nishiguchi S, Shiomi S, et al. Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma. Cancer Res 2001;61:1843-5.
33. Tan DJ, Bai RK, Wong LJ. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res 2002;62:972-6.
34. Wong LJ, Lueth M, Li XN, Lau CC, Vogel H. Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients. Cancer Res 2003;63:3866-71.
35. Hayashi JI, Takemitu M, Nonaka M. Recovery of the missing tumorigenicity in mitochondrial DNA-less HeLa cells by introduction of mitochondrial DNA from normal human cells. Somat Cell Mol Genet 1992;18:123-9.
36. Morais R, Zinkewich-Peotti K, Parent M, Wang H, Babai F, Zollinger M. Tumor-forming ability in athymic nude mice of human cell lines devoid of mitochondrial DNA. Cancer Res 1994;54:3889-96.
37. Kobayashi Y, Momoi MY, Tominaga K, et al. Respiration-deficient cells are caused by a single point mutation in the mitochondrial tRNA-Leu (UUR) gene in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Am J Hum Genet 1991;49:590-9.
38. Copeland WC, Wachsman JT, Johnson FM, Penta JS. Mitochondrial DNA alternations in cancer. Cancer Invest 2002;20:557-69.
39. Simonnet H, Alazard N, Pfeiffer K, et al. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis 2002;23:759-68.
40. 2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter-organelle crosstalk. EMBO J. 1999;18:522-33.
41. Shiraiwa N, Ishii A, Iwamoto H, Mizusawa H, Kagawa Y, Ohta S. Content of mutant mitochondrial DNA and organ dysfunction in a patient with a MELAS subgroup of mitochondrial encephalomyopathies. J Neurol Sci 1993;120:174-9.
42. Copeland WC, Wachsman JT, Johnson FM, Penta JS. Mitochondrial DNA alterations in cancer. Cancer Invest 2002;20:557-69.
43. Penta JS, Johnson FM, Wachsman JT, Copeland WC. Mitochondrial DNA in human malignancy. Mutat Res 2001;488:119-33.
44. Singh KK, Russell J, Sigara B, Zhang T, Williams J, Keshav KF. Mitochondrial DNA determines the cellular response to cancer therapeutic agents. Oncogene 1999;18:6641-6.
45. Jones JB, Song JJ, Hempen PM, Parmigiani G, Hurban RH, Kern SE. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 1993;361:365-9.
46. Wang J, Silva JP, Gustafsson CM, Rustin P, Larsson NG. Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression. Proc Natl Acad Sci U S A 2001;98:4038-43.
47. Cai J, Wallace DC, Zhivotovsky B, Jones DP. Separation of cytochrome c-dependent caspase activation from thiol-disulfide redox change in cell lacking mitochondria DNA. Free Radic Biol Med 2000;29:334-42.
48. Geromel V, Kadhom N, Cebalos-Picot I, et al. Superoxide-induced massive apoptosis in cultured skin fibroblasts harboring the neurogenic ataxia retinitis pigmentosa (NARP) mutation in the ATPase-6 gene of the mitochondrial DNA. Hum Mol Genet 2001;10:1221-8.